Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

TriPath Imaging Inc.

Jun 2006
TriPath Imaging Inc. of Burlington, N.C., has received the FDA’s 510(k) approval to use the Ki-67 cell proliferation biomarker with the Ventana Image Analysis System from Ventana Medical Systems Inc. of Tucson, Ariz. The biomarker enables pathologists to determine the percentage of tumor cells that are actively dividing with precise quantitative measurements of the biomarker’s expression in breast biopsy samples. The approach is expected to aid scientists in further investigations into the correlation between proliferation rate and survival.


Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!